Letter: cytokeratin-18 as a biomarker of hepatocellular carcinoma regression after transarterial chemoembolization. Authors' reply

Aliment Pharmacol Ther. 2017 Jan;45(1):184-185. doi: 10.1111/apt.13826.

Authors

H Bantel¹, F Wandrer¹, B Bock¹, M M Kirstein¹, K Schulze-Osthoff^{2

3}

Affiliations

¹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
² Interfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
³ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

PMID: 27910155
DOI: 10.1111/apt.13826

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic
Humans
Keratin-18*
Liver Neoplasms

Substances

Biomarkers
Keratin-18